Mutated p53 gene encodes a nonmutated epitope recognized by HLA-B*4601-restricted and tumor cell-reactive CTLs at tumor site

Cancer Research

Volumn 63, Issue 4, 2003, Pages 854-858

  Azuma, Koichi ^a   Shichijo, Shigeki ^a   Maeda, Yoshiaki ^a   Nakatsura, Tetsuya ^a   Nonaka, Yoichi ^a   Fujii, Teruhiko ^a   Koike, Kenta ^a   Itoh, Kyogo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA ANTIGEN CLASS 1; HLA B ANTIGEN; PHYTOHEMAGGLUTININ; PROTEIN P53;

AMINO ACID SEQUENCE; ANTIGEN RECOGNITION; ARTICLE; BLAST CELL; CANCER IMMUNOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DRUG TARGETING; GENE MUTATION; HUMAN; HUMAN CELL; LYMPHOCYTIC INFILTRATION; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MONONUCLEAR CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; GENES, P53; HLA-B ANTIGENS; HUMANS; LYMPHOCYTE ACTIVATION; MALE; NEOPLASMS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0037442699     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Hollstein, M., Sidransky, D., Vogelstein, B., and Harris, C. C. p53 mutations in human cancers. Science (Wash. DC), 253: 49-53, 1991.
2. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
3. Hussain, S. P., and Harris, C. C. Molecular epidemiology of human cancer: contribution of mutation spectra studies of tumor suppressor genes. Cancer Res., 58: 4023-4037, 1998.
4. Tilkin, A-F., Lubin, R., Soussi, T., Lazar, V., Janin, N., Mathieu, M-C., Léfrere, I., Carlu, C., Roy, M., Kayibanda, M., Bellet, D., Guillet, J.-G., and Paillerets, B. B. Primary proliferative T cell response wild-type p53 protein in patients with breast cancer. Eur. J. Immunol., 25: 1765-1769, 1995.
5. Soong, R., Robbins, P. D., Dix, B. R., Grieu, F., Lim, B., Knowles, S., Williams, K. E., Turbett, G. R., House, A. K., and Iacopetta, B. J. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum. Pathol., 27: 1050-1055, 1996.
6. Gnjatic, S., Cai, Z., Viguier, M., Chouaib, S., Guillet, J-G., and Choppin, J. Accumulation of the p53 protein allows recognition by human CTL of a wild-type p53 epitope presented by breast carcinomas and melanomas. J. Immunol., 160: 328-333, 1998.
7. Röpke, M., Hald, J., Guldberg, P., Zeuthen, J., Norgaard, L., Fugger, L., Svejgaard, A., Van der Burg, S., Nijman, H. W., Melief, C. J. M., and Claesson, M. H. Spontaneous human squamous cell carcinomas are killed by a human cytotoxic T lymphocyte clone recognizing a wild-type p53-derived peptide. Proc. Natl. Acad. Sci. USA, 93: 14704-14707, 1996.
8. van der Bruggen, P., Traversari, C., Chomez, P., Lurquin, C., De Plaen, E., Van den Eynde, B., Knuth, A., and Boon, T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science (Wash. DC), 254: 1643-1647, 1991.
9. Boon, T., and van der Bruggen, P. Human tumor antigens recognized by T lymphocytes. J. Exp. Med., 183: 725-729, 1996.
10. Shichijo, S., Nakao, M., Imai, Y., Takasu, H., Kawamoto, M., Niiya, F., Yang, D., Toh, Y., Yamana, H., and Itoh, K. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes. J. Exp. Med., 187: 277-288, 1998.
11. Ito, M., Shichijo, S., Tsuda, N., Ochi, M., Harashima, N., Saito, N., and Itoh, K. Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res., 61: 2038-2046, 2001.
12. Chaux, P., Luiten, R., Demotte, N., Vantomme, V., Stroobant, V., Traversari, C., Russo, V., Schultz, E., Cornelis, G. R., Boon, T., and van der Bruggen, P. Identification of five MACE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MACE-A1. J. Immunol., 163: 2928-2936, 1999.
13. Probst-Kepper, M., Stroobant, V., Kridel, R., Gaugler, B., Landry, C., Brasseur, F., Cosyns, J-P., Weynand, B., Boon, T., and Van den Eynde, B. An alternative open reading frame of the human macrophage colony-stimulating factor gene is independently translated and codes for an antigenic peptide of 14 amino acids recognized by tumor-infiltrating CD8 T lymphocytes. J. Exp. Med., 193: 1189-1198, 2001.
14. Imanishi, T., Akaza, T., Kimura, A., Tokunaga, K., and Gojobori, T. Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: Proceedings of the Eleventh International Histocompatibility Workshop and Conference, pp. 1065-1220. Oxford. United Kingdom: Oxford University Press, 1992.
15. Barber, L. D., Percival, L., Valiante, N. M., Chen, L., Lee, C., Gumperz, J. E., Phillips, J. H., Lanier, L. L., Bigge, J. C., Parekh, R. B., and Parham, P. The inter-locus recombinant HLA-B*4601 has high selectivity in peptide binding and functions characteristic of HLA-C. J. Exp. Med., 184: 735-740, 1996.
16. Lemonnier, F. A., Rebai, N., Le Bouteiller, P. P., Malissen, B., Caillol, D. H., and Kourilsky, F. M. Epitopic analysis of detergent-solubilized HLA molecules by solid-phase radioimmunoassay. J. Immunol. Methods, 54: 9-22, 1982.
17. Suzuki, N., Maeda, Y., Tanaka. S., Hida, N., Mine, T., Yamamoto, K., Oka, M., and Itoh, K. Detection of peptide-specific cytotoxic T-lymphocyte precursors used for specific immunotherapy of pancreatic cancer. Int. J. Cancer, 98: 45-50, 2002.
18. Nakajima, F., Nakamura, J., and Yokota, T. Analysis of HLA haplotypes in Japanese, using high resolution allele typing. MHC, 8: 1-32, 2001.
19. Walker, K. K., and Levine, A. J. Identification of a novel p53 functional domain that is necessary for efficient growth. Proc. Natl. Acad. Sci. USA. 93: 15335-15340, 1996.
20. Venot, C., Maratrat, M., Dureuil, C., Conseiller, E., Bracco, L., and Debussche, L. The requirement for the p53 proline-rich functional domain for mediation of apoptosis is correlated with specific PIG3 gene transactivation and with transcriptional repression. EMBO J., 17: 4668-4679, 1998.